Prolymphocytic Progression of Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: A Nationwide Veterans Affairs Retrospective Review

Saved in:
Bibliographic Details
Published in:Blood 2022-11, Vol.140 (Supplement 1), p.4176-4177
Main Authors: Lin, Chenyu, Scobie, Micaela R., Friedman, Daphne R., Kelley, Michael J., Rodgers, Thomas D.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 4177
container_issue Supplement 1
container_start_page 4176
container_title Blood
container_volume 140
creator Lin, Chenyu
Scobie, Micaela R.
Friedman, Daphne R.
Kelley, Michael J.
Rodgers, Thomas D.
description
doi_str_mv 10.1182/blood-2022-157414
format article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2022_157414</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497122033663</els_id><sourcerecordid>S0006497122033663</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1374-6e7438117a328e3893fa2e3d8e38661b0ded7e2e82c2b57ca47f6f0cae9c2f4d3</originalsourceid><addsrcrecordid>eNp9UEtOwzAUtBBIlMIB2PkCAdv5OIVVVZWPFBWEClvLtZ8bQxpHdmjVg3BfHMqCFav3mxnNG4QuKbmitGTXq8Y5nTDCWEJzntHsCI1ozsqEEEaO0YgQUiTZhNNTdBbCOyE0S1k-Ql_P3jX7TVc7te-twnFcewjBuhY7g2e1d21cV38gFXx-wMZKbFvc14DnXg7QhdtCg5fSr6EHjZc1eNlZCDd4iheyj4I7qwG_xauXbcBTY6T1Ab9A713oQPV2C3HaWtidoxMjmwAXv3WMXu_my9lDUj3dP86mVaJoyrOkAJ6lJaVcpqyEtJykRjJI9dAXBV0RDZoDg5Iptsq5khk3hSFKwkQxk-l0jOhBV0ULwYMRnbcb6feCEjHkKn5yFUOu4pBr5NweOBCNRbNeBGWhVaCtj08I7ew_7G_rrYQJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Prolymphocytic Progression of Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: A Nationwide Veterans Affairs Retrospective Review</title><source>ScienceDirect</source><creator>Lin, Chenyu ; Scobie, Micaela R. ; Friedman, Daphne R. ; Kelley, Michael J. ; Rodgers, Thomas D.</creator><creatorcontrib>Lin, Chenyu ; Scobie, Micaela R. ; Friedman, Daphne R. ; Kelley, Michael J. ; Rodgers, Thomas D.</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2022-157414</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Blood, 2022-11, Vol.140 (Supplement 1), p.4176-4177</ispartof><rights>2022 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0006497122033663$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27901,27902,45756</link.rule.ids></links><search><creatorcontrib>Lin, Chenyu</creatorcontrib><creatorcontrib>Scobie, Micaela R.</creatorcontrib><creatorcontrib>Friedman, Daphne R.</creatorcontrib><creatorcontrib>Kelley, Michael J.</creatorcontrib><creatorcontrib>Rodgers, Thomas D.</creatorcontrib><title>Prolymphocytic Progression of Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: A Nationwide Veterans Affairs Retrospective Review</title><title>Blood</title><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9UEtOwzAUtBBIlMIB2PkCAdv5OIVVVZWPFBWEClvLtZ8bQxpHdmjVg3BfHMqCFav3mxnNG4QuKbmitGTXq8Y5nTDCWEJzntHsCI1ozsqEEEaO0YgQUiTZhNNTdBbCOyE0S1k-Ql_P3jX7TVc7te-twnFcewjBuhY7g2e1d21cV38gFXx-wMZKbFvc14DnXg7QhdtCg5fSr6EHjZc1eNlZCDd4iheyj4I7qwG_xauXbcBTY6T1Ab9A713oQPV2C3HaWtidoxMjmwAXv3WMXu_my9lDUj3dP86mVaJoyrOkAJ6lJaVcpqyEtJykRjJI9dAXBV0RDZoDg5Iptsq5khk3hSFKwkQxk-l0jOhBV0ULwYMRnbcb6feCEjHkKn5yFUOu4pBr5NweOBCNRbNeBGWhVaCtj08I7ew_7G_rrYQJ</recordid><startdate>20221115</startdate><enddate>20221115</enddate><creator>Lin, Chenyu</creator><creator>Scobie, Micaela R.</creator><creator>Friedman, Daphne R.</creator><creator>Kelley, Michael J.</creator><creator>Rodgers, Thomas D.</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221115</creationdate><title>Prolymphocytic Progression of Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: A Nationwide Veterans Affairs Retrospective Review</title><author>Lin, Chenyu ; Scobie, Micaela R. ; Friedman, Daphne R. ; Kelley, Michael J. ; Rodgers, Thomas D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1374-6e7438117a328e3893fa2e3d8e38661b0ded7e2e82c2b57ca47f6f0cae9c2f4d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lin, Chenyu</creatorcontrib><creatorcontrib>Scobie, Micaela R.</creatorcontrib><creatorcontrib>Friedman, Daphne R.</creatorcontrib><creatorcontrib>Kelley, Michael J.</creatorcontrib><creatorcontrib>Rodgers, Thomas D.</creatorcontrib><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lin, Chenyu</au><au>Scobie, Micaela R.</au><au>Friedman, Daphne R.</au><au>Kelley, Michael J.</au><au>Rodgers, Thomas D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prolymphocytic Progression of Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: A Nationwide Veterans Affairs Retrospective Review</atitle><jtitle>Blood</jtitle><date>2022-11-15</date><risdate>2022</risdate><volume>140</volume><issue>Supplement 1</issue><spage>4176</spage><epage>4177</epage><pages>4176-4177</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><pub>Elsevier Inc</pub><doi>10.1182/blood-2022-157414</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2022-11, Vol.140 (Supplement 1), p.4176-4177
issn 0006-4971
1528-0020
language eng
recordid cdi_crossref_primary_10_1182_blood_2022_157414
source ScienceDirect
title Prolymphocytic Progression of Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: A Nationwide Veterans Affairs Retrospective Review
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T15%3A44%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prolymphocytic%20Progression%20of%20Chronic%20Lymphocytic%20Leukemia%20in%20the%20Era%20of%20Novel%20Targeted%20Therapies:%20A%20Nationwide%20Veterans%20Affairs%20Retrospective%20Review&rft.jtitle=Blood&rft.au=Lin,%20Chenyu&rft.date=2022-11-15&rft.volume=140&rft.issue=Supplement%201&rft.spage=4176&rft.epage=4177&rft.pages=4176-4177&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2022-157414&rft_dat=%3Celsevier_cross%3ES0006497122033663%3C/elsevier_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1374-6e7438117a328e3893fa2e3d8e38661b0ded7e2e82c2b57ca47f6f0cae9c2f4d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true